202 related articles for article (PubMed ID: 37773127)
21. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
22. LncRNA ANRIL promotes HR repair through regulating PARP1 expression by sponging miR-7-5p in lung cancer.
Du Z; Zhang F; Liu L; Shen H; Liu T; Jin J; Yu N; Wan Z; Wang H; Hu X; Chen Y; Cai J
BMC Cancer; 2023 Feb; 23(1):130. PubMed ID: 36755223
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of PRMT5 Attenuates Oxidative Stress-Induced Pyroptosis via Activation of the Nrf2/HO-1 Signal Pathway in a Mouse Model of Renal Ischemia-Reperfusion Injury.
Diao C; Chen Z; Qiu T; Liu H; Yang Y; Liu X; Wu J; Wang L
Oxid Med Cell Longev; 2019; 2019():2345658. PubMed ID: 31885778
[TBL] [Abstract][Full Text] [Related]
24. Preventing oxidation of cellular XRCC1 affects PARP-mediated DNA damage responses.
Horton JK; Stefanick DF; Gassman NR; Williams JG; Gabel SA; Cuneo MJ; Prasad R; Kedar PS; Derose EF; Hou EW; London RE; Wilson SH
DNA Repair (Amst); 2013 Sep; 12(9):774-85. PubMed ID: 23871146
[TBL] [Abstract][Full Text] [Related]
25. Forkhead box A2-mediated lncRNA SOX2OT up-regulation alleviates oxidative stress and apoptosis of renal tubular epithelial cells by promoting SIRT1 expression in diabetic nephropathy.
Ye G; Hu ML; Xiao L
Nephrology (Carlton); 2023 Mar; 28(3):196-207. PubMed ID: 36576135
[TBL] [Abstract][Full Text] [Related]
26. XRCC1 counteracts poly(ADP ribose)polymerase (PARP) poisons, olaparib and talazoparib, and a clinical alkylating agent, temozolomide, by promoting the removal of trapped PARP1 from broken DNA.
Hirota K; Ooka M; Shimizu N; Yamada K; Tsuda M; Ibrahim MA; Yamada S; Sasanuma H; Masutani M; Takeda S
Genes Cells; 2022 May; 27(5):331-344. PubMed ID: 35194903
[TBL] [Abstract][Full Text] [Related]
27. Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma
Ali R; Al-Kawaz A; Toss MS; Green AR; Miligy IM; Mesquita KA; Seedhouse C; Mirza S; Band V; Rakha EA; Madhusudan S
Cancer Res; 2018 Dec; 78(24):6818-6827. PubMed ID: 30297533
[TBL] [Abstract][Full Text] [Related]
28. Monomeric G-Quadruplex-Based CpG Oligodeoxynucleotides as Potent Toll-Like Receptor 9 Agonists.
Tu ATT; Hoshi K; Ikebukuro K; Hanagata N; Yamazaki T
Biomacromolecules; 2020 Sep; 21(9):3644-3657. PubMed ID: 32857497
[TBL] [Abstract][Full Text] [Related]
29. [Notoginsenoside R_1 interferes with renal oxidative stress and Nrf2/HO-1 signaling pathway to alleviate kidney injury in mice with IgA nephropathy and its mechanism].
Wu JK; Chen DP; Ye CY
Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(14):3839-3847. PubMed ID: 37475075
[TBL] [Abstract][Full Text] [Related]
30. Role of Oxidation of XRCC1 Protein in Regulation of Mammalian DNA Repair Process.
Vasil'eva IA; Moor NA; Lavrik OI
Dokl Biochem Biophys; 2019 Nov; 489(1):357-361. PubMed ID: 32130599
[TBL] [Abstract][Full Text] [Related]
31. Expression deregulation of genes related to DNA repair and lead toxicity in occupationally exposed industrial workers.
Akram Z; Mahjabeen I; Batool M; Kanwal S; Nawaz F; Kayani MA; Rizwan M
Int Arch Occup Environ Health; 2023 Dec; 96(10):1333-1347. PubMed ID: 37804366
[TBL] [Abstract][Full Text] [Related]
32. Expression of DNA repair genes and its relevance for DNA repair in peripheral immune cells of patients with posttraumatic stress disorder.
Behnke A; Mack M; Fieres J; Christmann M; Bürkle A; Moreno-Villanueva M; Kolassa IT
Sci Rep; 2022 Nov; 12(1):18641. PubMed ID: 36333408
[TBL] [Abstract][Full Text] [Related]
33. Human apurinic/apyrimidinic endonuclease 1 is modified in vitro by poly(ADP-ribose) polymerase 1 under control of the structure of damaged DNA.
Moor NA; Vasil'eva IA; Kuznetsov NA; Lavrik OI
Biochimie; 2020 Jan; 168():144-155. PubMed ID: 31668992
[TBL] [Abstract][Full Text] [Related]
34. Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo.
Shao Z; Lee BJ; Rouleau-Turcotte É; Langelier MF; Lin X; Estes VM; Pascal JM; Zha S
Nucleic Acids Res; 2020 Sep; 48(17):9694-9709. PubMed ID: 32890402
[TBL] [Abstract][Full Text] [Related]
35. CpG oligodeoxynucleotide 1826 enhances the Lewis lung cancer response to radiotherapy in murine tumor.
Yuan S; Qiao T; Chen W
Cancer Biother Radiopharm; 2011 Apr; 26(2):203-8. PubMed ID: 21539452
[TBL] [Abstract][Full Text] [Related]
36. SUMOylation of XRCC1 activated by poly (ADP-ribosyl)ation regulates DNA repair.
Hu LY; Chang CC; Huang YS; Chou WC; Lin YM; Ho CC; Chen WT; Shih HM; Hsiung CN; Wu PE; Shen CY
Hum Mol Genet; 2018 Jul; 27(13):2306-2317. PubMed ID: 29668892
[TBL] [Abstract][Full Text] [Related]
37. Protective effect of CpG-oligodeoxynucleotides against low- and high-LET irradiation.
Zhang C; Zheng M; Zhu XH; Li S; Ni J; Li BL; Liu H; Gao F; Cai JM
Cell Physiol Biochem; 2014; 34(5):1663-74. PubMed ID: 25401481
[TBL] [Abstract][Full Text] [Related]
38. PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancers.
Ali R; Alabdullah M; Alblihy A; Miligy I; Mesquita KA; Chan SY; Moseley P; Rakha EA; Madhusudan S
Cancer Lett; 2020 Jan; 469():124-133. PubMed ID: 31669203
[TBL] [Abstract][Full Text] [Related]
39. Class A CpG oligodeoxynucleotide inhibits IFN-γ-induced signaling and apoptosis in lung cancer.
Teranishi S; Kobayashi N; Katakura S; Kamimaki C; Kubo S; Shibata Y; Yamamoto M; Kudo M; Piao H; Kaneko T
Thorac Cancer; 2020 Apr; 11(4):983-992. PubMed ID: 32067413
[TBL] [Abstract][Full Text] [Related]
40. Functional Roles of PARP2 in Assembling Protein-Protein Complexes Involved in Base Excision DNA Repair.
Vasil'eva I; Moor N; Anarbaev R; Kutuzov M; Lavrik O
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
